Follow
Paul W Armstrong
Paul W Armstrong
professor medicine university alberta
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
75824*2016
Third universal definition of myocardial infarction
K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White
circulation 126 (16), 2020-2035, 2012
18993*2012
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart …
Writing Committee Members, EM Antman, DT Anbe, PW Armstrong, ...
Circulation 110 (5), 588-636, 2004
9690*2004
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
Gusto Investigators
New England Journal of Medicine 329 (10), 673-682, 1993
47241993
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ...
New England Journal of Medicine 373 (3), 232-242, 2015
31482015
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
Epic Investigators
New England Journal of Medicine 330 (14), 956-961, 1994
29951994
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article: a report of the American …
E Braunwald, EM Antman, JW Beasley, RM Califf, MD Cheitlin, ...
Journal of the American College of Cardiology 40 (7), 1366-1374, 2002
26722002
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
GUSTO Angiographic Investigators
New England Journal of Medicine 329 (22), 1615-1622, 1993
21421993
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
M Packer, PA Poole-Wilson, PW Armstrong, JGF Cleland, JD Horowitz, ...
Circulation 100 (23), 2312-2318, 1999
17981999
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
PURSUIT Trial Investigators
New England Journal of Medicine 339 (7), 436-443, 1998
16781998
Cardiac troponin T levels for risk stratification in acute myocardial ischemia
EM Ohman, PW Armstrong, RH Christenson, CB Granger, HA Katus, ...
New England Journal of Medicine 335 (18), 1333-1342, 1996
15111996
Effect of nesiritide in patients with acute decompensated heart failure
CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ...
New England Journal of Medicine 365 (1), 32-43, 2011
14512011
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
E Boersma, RA Harrington, DJ Moliterno, H White, P Théroux, ...
The Lancet 359 (9302), 189-198, 2002
14142002
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients
E Boersma, KS Pieper, EW Steyerberg, RG Wilcox, WC Chang, KL Lee, ...
Circulation 101 (22), 2557-2567, 2000
13532000
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure
JA Ezekowitz, FA McAlister, PW Armstrong
Circulation 107 (2), 223-225, 2003
13522003
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
SV Rao, JG Jollis, RA Harrington, CB Granger, LK Newby, PW Armstrong, ...
Jama 292 (13), 1555-1562, 2004
12182004
Acute coronary care in the elderly, part I: non–ST-segment–elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart …
KP Alexander, LK Newby, CP Cannon, PW Armstrong, WB Gibler, ...
Circulation 115 (19), 2549-2569, 2007
1214*2007
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
PW Armstrong, AH Gershlick, P Goldstein, R Wilcox, T Danays, Y Lambert, ...
New England Journal of Medicine 368 (15), 1379-1387, 2013
11302013
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ...
New England journal of medicine 367 (14), 1297-1309, 2012
10862012
Vericiguat in patients with heart failure and reduced ejection fraction
PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ...
New England Journal of Medicine 382 (20), 1883-1893, 2020
10732020
The system can't perform the operation now. Try again later.
Articles 1–20